Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $2,614 | 2 | 57.8% |
| Consulting Fee | $1,750 | 1 | 38.7% |
| Food and Beverage | $155.06 | 3 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Goode Surgical Inc | $2,614 | 2 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $1,750 | 1 | $0 (2021) |
| Stryker Corporation | $85.00 | 1 | $0 (2019) |
| PFIZER INC. | $36.89 | 1 | $0 (2023) |
| Bioventus LLC | $33.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $36.89 | 1 | PFIZER INC. ($36.89) |
| 2021 | $1,750 | 1 | Janssen Scientific Affairs, LLC ($1,750) |
| 2020 | $2,614 | 2 | Goode Surgical Inc ($2,614) |
| 2019 | $118.17 | 2 | Stryker Corporation ($85.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: Inflammation & Immunology | ||||||
| 11/30/2021 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Immunology | ||||||
| 08/21/2020 | Goode Surgical Inc | — | Education | In-kind items and services | $852.06 | General |
| 08/20/2020 | Goode Surgical Inc | — | Education | In-kind items and services | $1,761.68 | General |
| 08/09/2019 | Stryker Corporation | NONE (Device) | Food and Beverage | Cash or cash equivalent | $85.00 | General |
| Category: NONE | ||||||
| 04/24/2019 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 855 | 1,646 | $444,074 | $67,715 |
| 2022 | 9 | 796 | 1,441 | $371,672 | $61,080 |
| 2021 | 9 | 759 | 1,349 | $356,320 | $63,642 |
| 2020 | 9 | 754 | 1,228 | $324,331 | $48,232 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 204 | $62,475 | $19,202 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 232 | $53,981 | $14,682 | 27.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 80 | 88 | $72,932 | $8,288 | 11.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 133 | 170 | $78,073 | $7,284 | 9.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 71 | $60,847 | $5,442 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 53 | $9,157 | $3,996 | 43.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 110 | 657 | $59,043 | $3,498 | 5.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 35 | $28,161 | $1,548 | 5.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 31 | $2,883 | $1,479 | 51.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 12 | 14 | $6,454 | $738.79 | 11.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,268 | $700.96 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 15 | 18 | $3,690 | $509.21 | 13.8% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 11 | 12 | $1,560 | $300.25 | 19.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 11 | 50 | $1,550 | $46.89 | 3.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 216 | $49,113 | $14,149 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 131 | $35,910 | $12,447 | 34.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 70 | $57,428 | $6,732 | 11.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 111 | 133 | $60,270 | $6,026 | 10.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 64 | 71 | $60,253 | $5,786 | 9.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 92 | 538 | $47,608 | $3,175 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 42 | $5,880 | $3,047 | 51.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $9,610 | $2,953 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,790 | $2,029 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 43 | $3,999 | $2,022 | 50.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 20 | 34 | $26,846 | $1,583 | 5.9% |
About Dr. Temitayo Ogunleye, MD
Dr. Temitayo Ogunleye, MD is a Dermatology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891956595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Temitayo Ogunleye, MD has received a total of $4,519 in payments from pharmaceutical and medical device companies, with $36.89 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Education" ($2,614).
As a Medicare-enrolled provider, Ogunleye has provided services to 3,164 Medicare beneficiaries, totaling 5,664 services with total Medicare billing of $240,670. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Philadelphia, PA
- Active Since 06/24/2008
- Last Updated 07/02/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1891956595
Products in Payments
- TREMFYA (Drug) $1,750
- NONE (Device) $85.00
- CIBINQO (Drug) $36.89
- GELSYN 3 (Device) $33.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Philadelphia
Stephen Hess, Md, MD
Dermatology — Payments: $1.8M
David Margolis, Md, MD
Dermatology — Payments: $1.1M
Joel Gelfand, Md, MD
Dermatology — Payments: $787,044
Victoria Werth, Md, MD
Dermatology — Payments: $555,094
Dr. Harold Farber, M.d,, M.D,
Dermatology — Payments: $484,640
Dr. Lawrence Parish, Md, MD
Dermatology — Payments: $406,273